Here are the latest quarterly results of VENUS REMEDIES. For more details, see the VENUS REMEDIES financial fact sheet and VENUS REMEDIES share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,425 | 1,431 | 1,399 | 1,169 | 1,556 | 952 | 1,677 | 1,434 | |
Other income | Rs m | 23 | 14 | 18 | 38 | 34 | 23 | 31 | 24 | |
Turnover | Rs m | 1,447 | 1,445 | 1,417 | 1,207 | 1,591 | 974 | 1,708 | 1,458 | |
Expenses | Rs m | 1,369 | 1,286 | 1,269 | 1,088 | 1,310 | 848 | 1,499 | 1,314 | |
Gross profit | Rs m | 55 | 145 | 130 | 81 | 246 | 104 | 178 | 120 | |
Depreciation | Rs m | 76 | 78 | 90 | 72 | 83 | 76 | 64 | 65 | |
Interest | Rs m | 0 | 3 | 0 | 2 | 0 | 1 | 1 | 1 | |
Profit before tax | Rs m | 2 | 79 | 58 | 45 | 197 | 51 | 143 | 78 | |
Tax | Rs m | 0 | 10 | 4 | 13 | 87 | 39 | 44 | 9 | |
Profit after tax | Rs m | 2 | 69 | 53 | 33 | 111 | 12 | 99 | 69 | |
Gross profit margin | % | 3.9 | 10.1 | 9.3 | 6.9 | 15.8 | 10.9 | 10.6 | 8.4 | |
Effective tax rate | % | 0.0 | 12.7 | 7.6 | 27.5 | 43.9 | 76.6 | 30.7 | 12.0 | |
Net profit margin | % | 0.2 | 4.8 | 3.8 | 2.8 | 7.1 | 1.2 | 5.9 | 4.8 | |
Diluted EPS | Rs | 0.2 | 5.2 | 4.0 | 2.5 | 8.3 | 0.9 | 7.4 | 5.1 | |
Diluted EPS (TTM) | Rs | 30.5 | 26.9 | 13.5 | 11.8 | 19.9 | 15.6 | 19.1 | 21.7 | |
Subscriber Feature |
Japan's Nikkei 225 led gains in Asia as markets in the region rose across the board, following Wall Street's continued rally for a second straight day.